Hanmi Science Co., Ltd. (KRX:008930)
South Korea · Delayed Price · Currency is KRW 41,700
+300 (0.72%)
Oct 28, 2026, 2:50 PM KST
Hanmi Science Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,408,098 | 1,356,958 | 1,283,432 | 1,247,906 | 1,046,054 | 950,165 |
Revenue Growth | 10.00% | 5.73% | 2.85% | 19.30% | 10.09% | 10.82% |
Gross Profit Gross Profit Growth | 333,349 | 311,308 | 268,280 | 261,455 | 159,694 | 948,491 |
Operating Income Operating Income Growth | 67,021 | 56,964 | 37,958 | 57,012 | 28,112 | 28,753 |
Net Income Net Income Growth | 150,915 | 118,370 | 59,422 | 115,122 | 69,210 | 42,942 |
Earnings Per Share EPS Growth | 2226.81 | 1747.00 | 877.52 | 1694.06 | 1010.45 | 625.80 |
EPS Growth | 148.47% | 99.08% | -48.20% | 67.66% | 61.47% | 90.04% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Holding Company Division Holding Company Division Growth | 93,798 | 76,346 | 64,057 | 66,304 | 39,040 | 36,331 |
Other Categories Other Categories Growth | 19,576 | 19,438 | 19,130 | 15,541 | 4,523 | 2,096 |
Healthcare Business Division Healthcare Business Division Growth | 160,490 | 155,106 | 129,467 | 120,123 | 18,450 | - |
Pharmaceutical Wholesale Division Pharmaceutical Wholesale Division Growth | 1,179,178 | 1,136,683 | 1,100,334 | 1,071,207 | 990,058 | 916,529 |
Unallocated Adjustment and Removal Unallocated Adjustment and Removal Growth | -44,944 | -30,615 | -29,556 | -25,268 | -6,017 | -4,791 |
Total Total Growth | 1,408,098 | 1,356,958 | 1,283,432 | 1,247,906 | 1,046,054 | 950,165 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 98,924 | 128,173 | 89,246 | 34,508 | 21,513 | 16,630 |
Total Debt Total Debt Growth | 183,952 | 214,531 | 217,352 | 213,736 | 202,003 | 56,494 |
Net Cash (Debt) Net Cash Growth | -85,028 | -86,358 | -128,106 | -179,228 | -180,489 | -39,865 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1254.71 | -1274.64 | -1891.84 | -2637.42 | -2635.12 | -580.95 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 46,886 | 47,658 | 82,986 | 35,158 | 9,452 | 13,690 |
Capital Expenditures CapEx Growth | -19,036 | -18,928 | -9,833 | -6,930 | -7,398 | -1,816 |
Free Cash Flow Free Cash Flow Growth | 27,851 | 28,730 | 73,154 | 28,228 | 2,054 | 11,874 |
Free Cash Flow Growth | -56.87% | -60.73% | 159.15% | 1274.19% | -82.70% | -7.66% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 23.67% | 22.94% | 20.90% | 20.95% | 15.27% | 99.82% |
Operating Margin | 4.76% | 4.20% | 2.96% | 4.57% | 2.69% | 3.03% |
Pretax Margin | 12.55% | 9.80% | 4.92% | 10.46% | 7.00% | 5.17% |
Profit Margin | 10.72% | 8.72% | 4.63% | 9.22% | 6.62% | 4.52% |
FCF Margin | 1.98% | 2.12% | 5.70% | 2.26% | 0.20% | 1.25% |
Fiscal Year | Current | FY 2025 |
|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 |
Dividend Per Share Dividend Per Share Growth | 300.000 | 300.000 |
Dividend Per Share Growth | 0% | - |
Dividend Yield | 0.72% | 0.83% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.73 | 20.74 | 33.56 | 23.15 | 31.88 | 84.91 |
P/FCF Ratio | 100.71 | 85.44 | 27.26 | 94.41 | 1074.16 | 307.07 |
PS Ratio | 1.99 | 1.81 | 1.55 | 2.14 | 2.11 | 3.84 |